New and emerging therapies for bone metastases in genitourinary cancers.
(2013) European Urology — Vol. 63, n° 2, p. 309-320 (2013)
Files
Saylor-2013-NewandEmergingtherapies.pdf
Restricted Access - Adobe PDF
- 822.35 KB
Details
- Authors
- Abstract
- Bone metastases cause considerable morbidity and mortality among patients with genitourinary malignancies. Optimal management requires consideration of bone-targeted therapy as well as disease-specific therapy. Further research is needed to optimize the use of existing agents and to define the therapeutic potential of novel targets.
- Affiliations
Citations
Saylor, P. J., Armstrong, A. J., Fizazi, K., Freedland, S., Saad, F., Smith, M. R., Tombal, B., & Pienta, K. (2013). New and emerging therapies for bone metastases in genitourinary cancers. European Urology, 63(2), 309-320. https://doi.org/10.1016/j.eururo.2012.10.007 (Original work published 2013)